Logo image of ZVIA

ZEVIA PBC-A (ZVIA) Stock Fundamental Analysis

USA - NYSE:ZVIA - US98955K1043 - Common Stock

2.3 USD
-0.06 (-2.54%)
Last: 10/7/2025, 8:04:00 PM
2.3 USD
0 (0%)
After Hours: 10/7/2025, 8:04:00 PM
Fundamental Rating

4

ZVIA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 33 industry peers in the Beverages industry. No worries on liquidiy or solvency for ZVIA as it has an excellent financial health rating, but there are worries on the profitability. While showing a medium growth rate, ZVIA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ZVIA has reported negative net income.
In the past year ZVIA has reported a negative cash flow from operations.
In the past 5 years ZVIA always reported negative net income.
In the past 5 years ZVIA always reported negative operating cash flow.
ZVIA Yearly Net Income VS EBIT VS OCF VS FCFZVIA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

ZVIA has a worse Return On Assets (-22.76%) than 84.85% of its industry peers.
The Return On Equity of ZVIA (-26.81%) is worse than 84.85% of its industry peers.
Industry RankSector Rank
ROA -22.76%
ROE -26.81%
ROIC N/A
ROA(3y)-29.12%
ROA(5y)-27.27%
ROE(3y)-28.52%
ROE(5y)-27.7%
ROIC(3y)N/A
ROIC(5y)N/A
ZVIA Yearly ROA, ROE, ROICZVIA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

ZVIA has a Gross Margin of 49.25%. This is comparable to the rest of the industry: ZVIA outperforms 57.58% of its industry peers.
ZVIA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for ZVIA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 49.25%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.56%
GM growth 5Y1.48%
ZVIA Yearly Profit, Operating, Gross MarginsZVIA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

8

2. Health

2.1 Basic Checks

ZVIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ZVIA has been increased compared to 1 year ago.
Compared to 5 years ago, ZVIA has more shares outstanding
There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ZVIA Yearly Shares OutstandingZVIA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M
ZVIA Yearly Total Debt VS Total AssetsZVIA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 10.86 indicates that ZVIA is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 10.86, ZVIA belongs to the best of the industry, outperforming 90.91% of the companies in the same industry.
There is no outstanding debt for ZVIA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 10.86
ROIC/WACCN/A
WACC8.82%
ZVIA Yearly LT Debt VS Equity VS FCFZVIA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

ZVIA has a Current Ratio of 2.34. This indicates that ZVIA is financially healthy and has no problem in meeting its short term obligations.
ZVIA's Current ratio of 2.34 is fine compared to the rest of the industry. ZVIA outperforms 75.76% of its industry peers.
A Quick Ratio of 1.69 indicates that ZVIA should not have too much problems paying its short term obligations.
ZVIA has a Quick ratio of 1.69. This is amongst the best in the industry. ZVIA outperforms 84.85% of its industry peers.
Industry RankSector Rank
Current Ratio 2.34
Quick Ratio 1.69
ZVIA Yearly Current Assets VS Current LiabilitesZVIA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 63.27% over the past year.
Looking at the last year, ZVIA shows a decrease in Revenue. The Revenue has decreased by -1.09% in the last year.
Measured over the past years, ZVIA shows a quite strong growth in Revenue. The Revenue has been growing by 12.62% on average per year.
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.89%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y3.91%
Revenue growth 5Y12.62%
Sales Q2Q%10.14%

3.2 Future

ZVIA is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.70% yearly.
ZVIA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.26% yearly.
EPS Next Y44.89%
EPS Next 2Y30.53%
EPS Next 3Y21.7%
EPS Next 5YN/A
Revenue Next Year4.41%
Revenue Next 2Y5.54%
Revenue Next 3Y6.26%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ZVIA Yearly Revenue VS EstimatesZVIA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ZVIA Yearly EPS VS EstimatesZVIA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ZVIA. In the last year negative earnings were reported.
Also next year ZVIA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZVIA Price Earnings VS Forward Price EarningsZVIA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZVIA Per share dataZVIA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

ZVIA's earnings are expected to grow with 21.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.53%
EPS Next 3Y21.7%

0

5. Dividend

5.1 Amount

ZVIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ZEVIA PBC-A

NYSE:ZVIA (10/7/2025, 8:04:00 PM)

After market: 2.3 0 (0%)

2.3

-0.06 (-2.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)N/A N/A
Inst Owners58.97%
Inst Owner Change0%
Ins Owners4.75%
Ins Owner Change-3.55%
Market Cap172.38M
Analysts80
Price Target4.96 (115.65%)
Short Float %3.41%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.88%
Min EPS beat(2)54.05%
Max EPS beat(2)77.72%
EPS beat(4)3
Avg EPS beat(4)42.41%
Min EPS beat(4)-12.04%
Max EPS beat(4)77.72%
EPS beat(8)7
Avg EPS beat(8)24.73%
EPS beat(12)11
Avg EPS beat(12)31.24%
EPS beat(16)13
Avg EPS beat(16)8.88%
Revenue beat(2)2
Avg Revenue beat(2)2.47%
Min Revenue beat(2)0.34%
Max Revenue beat(2)4.61%
Revenue beat(4)2
Avg Revenue beat(4)-1.47%
Min Revenue beat(4)-9.04%
Max Revenue beat(4)4.61%
Revenue beat(8)4
Avg Revenue beat(8)-0.21%
Revenue beat(12)6
Avg Revenue beat(12)-0.16%
Revenue beat(16)7
Avg Revenue beat(16)-0.71%
PT rev (1m)0%
PT rev (3m)17.98%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-64.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-3.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.09%
Revenue NY rev (1m)0.19%
Revenue NY rev (3m)0.74%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.09
P/FCF N/A
P/OCF N/A
P/B 3.25
P/tB 3.45
EV/EBITDA N/A
EPS(TTM)-0.18
EYN/A
EPS(NY)-0.09
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.03
OCFYN/A
SpS2.11
BVpS0.71
TBVpS0.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -22.76%
ROE -26.81%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 49.25%
FCFM N/A
ROA(3y)-29.12%
ROA(5y)-27.27%
ROE(3y)-28.52%
ROE(5y)-27.7%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.56%
GM growth 5Y1.48%
F-Score5
Asset Turnover2.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 21.64%
Cap/Sales 0.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.34
Quick Ratio 1.69
Altman-Z 10.86
F-Score5
WACC8.82%
ROIC/WACCN/A
Cap/Depr(3y)104.57%
Cap/Depr(5y)142.96%
Cap/Sales(3y)0.92%
Cap/Sales(5y)1.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%88.89%
EPS Next Y44.89%
EPS Next 2Y30.53%
EPS Next 3Y21.7%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y3.91%
Revenue growth 5Y12.62%
Sales Q2Q%10.14%
Revenue Next Year4.41%
Revenue Next 2Y5.54%
Revenue Next 3Y6.26%
Revenue Next 5YN/A
EBIT growth 1Y60.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.09%
EBIT Next 3Y30.65%
EBIT Next 5YN/A
FCF growth 1Y2.72%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1406.88%
OCF growth 3YN/A
OCF growth 5YN/A